Director at Merit Medical (MMSI) receives 3,457 RSUs equity grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Evans Stephen C. reported acquisition or exercise transactions in this Form 4 filing.

Merit Medical Systems director Stephen C. Evans received a grant of 3,457 restricted stock units (RSUs). The award was made as common stock on a grant/award basis at no cash cost and increases his directly held common shares to 10,266 after the transaction.

The RSUs were granted under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan and will vest on May 3, 2027, subject to his continued service with the company through that vesting date. This is a routine equity compensation grant rather than an open-market share purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Evans Stephen C.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, No Par Value	3,457	$0.00	--

Holdings After Transaction: Common Stock, No Par Value — 10,266 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant: 3,457 RSUs Shares after transaction: 10,266 shares Grant price: $0.0000 per share +1 more

4 metrics

RSU grant 3,457 RSUs Grant of restricted stock units to director Stephen C. Evans

Shares after transaction 10,266 shares Common stock directly held by Evans following the grant

Grant price $0.0000 per share Reported transaction price for the RSU award

Vesting date May 3, 2027 RSUs vesting date, subject to continued service

Key Terms

restricted stock units (RSUs), 2026 Equity Incentive Plan, vesting, Form 4

4 terms

restricted stock units (RSUs) financial

"The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

2026 Equity Incentive Plan financial

"The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan."

vesting financial

"The RSUs granted to the reporting person will vest on May 3, 2027."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

05/19/2026 - 06:09 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Evans Stephen C.

(Last)

(First)

(Middle)

1600 WEST MERIT PARKWAY

(Street)

SOUTH JORDAN

UTAH

84095

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, No Par Value	05/18/2026		A		3,457⁽¹⁾	A	$0	10,266	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

	/s/ Brian G. Lloyd, Attorney-in-Fact	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did MMSI director Stephen C. Evans report?

Stephen C. Evans reported receiving 3,457 restricted stock units (RSUs) of Merit Medical Systems common stock. The grant was a compensation award, not an open-market trade, and was reported on a Form 4 as a non-derivative acquisition.

How many MMSI shares does Stephen C. Evans hold after this RSU grant?

After the grant, Stephen C. Evans directly holds 10,266 shares of Merit Medical Systems common stock. This total reflects the addition of the 3,457 RSUs awarded to him, as disclosed in the Form 4 insider filing for this transaction.

When do Stephen C. Evans’s 3,457 MMSI RSUs vest?

The 3,457 restricted stock units granted to Stephen C. Evans vest on May 3, 2027. Vesting is conditional on his continued service to Merit Medical Systems through that date, as specified in the equity award footnote.

Under which plan were the 3,457 MMSI RSUs granted to Stephen C. Evans?

The 3,457 restricted stock units were granted under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. This plan provides equity-based compensation awards such as RSUs to eligible participants, including company directors like Evans.

Did Stephen C. Evans buy or sell MMSI shares in the market?

He did not buy or sell shares in the open market. The Form 4 shows a grant of 3,457 restricted stock units as a compensation award, with a transaction price per share of $0.0000, rather than a purchase or sale transaction.